Mayne Pharma 被Wilsons從增持下調至市場權重 >MYX.AU
道瓊斯02/27 05:54
Canaccord Genuity將Mayne Pharma的目標股價下調6.6%,至A$6.25/股
道瓊斯2024/08/26 12:24
解鎖榜首股票